Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Proc Natl Acad Sci U S A
2006 Oct 10;10341:15248-53. doi: 10.1152/ajpcell.00265.2006.
Show Gene links
Show Anatomy links
Activation, internalization, and recycling of the serotonin 2A receptor by dopamine.
Bhattacharyya S, Raote I, Bhattacharya A, Miledi R, Panicker MM.
???displayArticle.abstract???
Serotonergic and dopaminergic systems, and their functional interactions, have been implicated in the pathophysiology of various CNS disorders. Here, we use recombinant serotonin (5-HT) 2A (5-HT2A) receptors to further investigate direct interactions between dopamine and 5-HT receptors. Previous studies in Xenopus oocytes showed that dopamine, although not the cognate ligand for the 5-HT2A receptor, acts as a partial-efficacy agonist. At micromolar concentrations, dopamine also acts as a partial-efficacy agonist on 5-HT2A receptors in HEK293 cells. Like 5-HT, dopamine also induces receptor-internalization in these cells, although at significantly higher concentrations than 5-HT. Interestingly, if the receptors are first sensitized or "primed" by subthreshold concentrations of 5-HT, then dopamine-induced internalization occurs at concentrations approximately 10-fold lower than when dopamine is used alone. Furthermore, unlike 5-HT-mediated internalization, dopamine-mediated receptor internalization, alone, or after sensitization by 5-HT, does not depend on PKC. Dopamine-internalized receptors recycle to the surface at rates similar to those of 5-HT-internalized receptors. Our results suggest a previously uncharacterized role for dopamine in the direct activation and internalization of 5-HT2A receptors that may have clinical relevance to the function of serotonergic systems in anxiety, depression, and schizophrenia and also to the treatment of these disorders.
Auclair,
Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
2004, Pubmed
Auclair,
Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
2004,
Pubmed Banes,
Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle.
1999,
Pubmed Berg,
Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus.
1998,
Pubmed Bhattacharyya,
Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms.
2002,
Pubmed Bortolozzi,
The activation of 5-HT receptors in prefrontal cortex enhances dopaminergic activity.
2005,
Pubmed Bouvier,
Oligomerization of G-protein-coupled transmitter receptors.
2001,
Pubmed Dautry-Varsat,
pH and the recycling of transferrin during receptor-mediated endocytosis.
1983,
Pubmed Doherty,
Ultrastructural localization of the serotonin 2A receptor in dopaminergic neurons in the ventral tegmental area.
2000,
Pubmed Esposito,
Serotonin-dopamine interaction as a focus of novel antidepressant drugs.
2006,
Pubmed Garris,
Real-time measurement of electrically evoked extracellular dopamine in the striatum of freely moving rats.
1997,
Pubmed Gobert,
Serotonin (5-HT)2A receptor activation enhances dialysate levels of dopamine and noradrenaline, but not 5-HT, in the frontal cortex of freely-moving rats.
1999,
Pubmed Guillet-Deniau,
Identification and localization of a skeletal muscle secrotonin 5-HT2A receptor coupled to the Jak/STAT pathway.
1997,
Pubmed Herrick-Davis,
Inhibition of serotonin 5-hydroxytryptamine2c receptor function through heterodimerization: receptor dimers bind two molecules of ligand and one G-protein.
2005,
Pubmed Herrick-Davis,
Biochemical and biophysical characterization of serotonin 5-HT2C receptor homodimers on the plasma membrane of living cells.
2004,
Pubmed Ikemoto,
Human midbrain dopamine neurons express serotonin 2A receptor: an immunohistochemical demonstration.
2000,
Pubmed Iyer,
Serotonin-mediated increase in prefrontal cortex dopamine release: pharmacological characterization.
1996,
Pubmed Kahn,
Serotonin, dopamine and their interactions in schizophrenia.
1993,
Pubmed Kosten,
Depression and stimulant dependence: neurobiology and pharmacotherapy.
1998,
Pubmed Kurrasch-Orbaugh,
A complex signaling cascade links the serotonin2A receptor to phospholipase A2 activation: the involvement of MAP kinases.
2003,
Pubmed Lamb,
Internalization and subcellular localization of transferrin and transferrin receptors in HeLa cells.
1983,
Pubmed Lucas,
Role of striatal serotonin2A and serotonin2C receptor subtypes in the control of in vivo dopamine outflow in the rat striatum.
2000,
Pubmed Matsui-Sakata,
Pharmacokinetic-pharmacodynamic analysis of antipsychotics-induced extrapyramidal symptoms based on receptor occupancy theory incorporating endogenous dopamine release.
2005,
Pubmed McBride,
CNS mechanisms of alcohol self-administration.
1993,
Pubmed Meltzer,
The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs.
1989,
Pubmed Meltzer,
Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.
1989,
Pubmed Ohkura,
Insulin induces internalization of the 5-HT2A receptor expressed in HEK293 cells.
2005,
Pubmed Oz,
Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
2003,
Pubmed
,
Xenbase Pehek,
M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.
2001,
Pubmed Pehek,
Evidence for the preferential involvement of 5-HT2A serotonin receptors in stress- and drug-induced dopamine release in the rat medial prefrontal cortex.
2006,
Pubmed Quinn,
Activation of extracellular-regulated kinase by 5-hydroxytryptamine(2A) receptors in PC12 cells is protein kinase C-independent and requires calmodulin and tyrosine kinases.
2002,
Pubmed Rocheville,
Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.
2000,
Pubmed Schlierf,
Rab11b is essential for recycling of transferrin to the plasma membrane.
2000,
Pubmed Schmidt,
The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat.
1995,
Pubmed Turner,
Interaction of calmodulin with the serotonin 5-hydroxytryptamine2A receptor. A putative regulator of G protein coupling and receptor phosphorylation by protein kinase C.
2005,
Pubmed Urban,
Functional selectivity and classical concepts of quantitative pharmacology.
2007,
Pubmed Woodward,
Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes.
1992,
Pubmed
,
Xenbase Xia,
The PDZ-binding domain is essential for the dendritic targeting of 5-HT2A serotonin receptors in cortical pyramidal neurons in vitro.
2003,
Pubmed Xie,
Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed.
1999,
Pubmed Yatham,
Atypical antipsychotics in bipolar depression: potential mechanisms of action.
2005,
Pubmed
